Thi-Thu-Trang Luu

448 total citations
9 papers, 352 citations indexed

About

Thi-Thu-Trang Luu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Thi-Thu-Trang Luu has authored 9 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Thi-Thu-Trang Luu's work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer Mechanisms and Therapy (2 papers) and Phagocytosis and Immune Regulation (2 papers). Thi-Thu-Trang Luu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Cancer Mechanisms and Therapy (2 papers) and Phagocytosis and Immune Regulation (2 papers). Thi-Thu-Trang Luu collaborates with scholars based in South Korea, Puerto Rico and United States. Thi-Thu-Trang Luu's co-authors include Sang Kook Lee, Duc‐Hiep Bach, Donghwa Kim, Hyen Joo Park, Ji‐Young Hong, Yanhua Fan, Nguyen Phuoc Long, Nguyễn Hoàng Anh, Sung Won Kwon and Won Kyung Kim and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and RSC Advances.

In The Last Decade

Thi-Thu-Trang Luu

9 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thi-Thu-Trang Luu South Korea 8 231 102 96 73 45 9 352
Irene Marchesi Italy 14 315 1.4× 107 1.0× 85 0.9× 74 1.0× 46 1.0× 23 452
Carmen Oi Ning Leung Hong Kong 9 265 1.1× 88 0.9× 97 1.0× 50 0.7× 55 1.2× 17 405
Yichao Gan China 9 354 1.5× 120 1.2× 96 1.0× 42 0.6× 23 0.5× 20 515
Aubhishek Zaman United States 8 223 1.0× 91 0.9× 64 0.7× 40 0.5× 21 0.5× 9 359
Amanda B. Parris United States 15 254 1.1× 126 1.2× 96 1.0× 51 0.7× 20 0.4× 22 409
Shaowen Jiang United States 3 419 1.8× 85 0.8× 149 1.6× 78 1.1× 28 0.6× 5 524
Seung Yeob Hyun South Korea 13 264 1.1× 80 0.8× 82 0.9× 31 0.4× 38 0.8× 14 371
Arnatchai Maiuthed Thailand 12 187 0.8× 97 1.0× 83 0.9× 31 0.4× 21 0.5× 22 341
Changtian Yin China 8 309 1.3× 68 0.7× 138 1.4× 53 0.7× 22 0.5× 11 412
Dong-Jin Ye South Korea 10 214 0.9× 83 0.8× 72 0.8× 40 0.5× 23 0.5× 16 327

Countries citing papers authored by Thi-Thu-Trang Luu

Since Specialization
Citations

This map shows the geographic impact of Thi-Thu-Trang Luu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thi-Thu-Trang Luu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thi-Thu-Trang Luu more than expected).

Fields of papers citing papers by Thi-Thu-Trang Luu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thi-Thu-Trang Luu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thi-Thu-Trang Luu. The network helps show where Thi-Thu-Trang Luu may publish in the future.

Co-authorship network of co-authors of Thi-Thu-Trang Luu

This figure shows the co-authorship network connecting the top 25 collaborators of Thi-Thu-Trang Luu. A scholar is included among the top collaborators of Thi-Thu-Trang Luu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thi-Thu-Trang Luu. Thi-Thu-Trang Luu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Luu, Thi-Thu-Trang, et al.. (2020). Overexpression of AGR2 Is Associated With Drug Resistance in Mutant Non-small Cell Lung Cancers. Anticancer Research. 40(4). 1855–1866. 15 indexed citations
2.
Hoang, Van-Hai, Thi-Thu-Trang Luu, Hung N. Luu, et al.. (2020). Design, synthesis and bioevaluation of novel 6-substituted aminoindazole derivatives as anticancer agents. RSC Advances. 10(73). 45199–45206. 7 indexed citations
3.
Kim, Donghwa, Duc‐Hiep Bach, Yanhua Fan, et al.. (2019). AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells. Cell Death and Disease. 10(5). 361–361. 76 indexed citations
4.
Kim, Donghwa, Duc‐Hiep Bach, Yanhua Fan, et al.. (2019). Abstract 337: Degradation of AXL overcome acquired cross-resistance to gefitinib and osimertinib in non-small cell lung cancer cells. Cancer Research. 79(13_Supplement). 337–337. 1 indexed citations
5.
Kim, Donghwa, Cai Yi Wang, Ji Yun Lee, et al.. (2019). Antitumor Activity of Vanicoside B Isolated from Persicaria dissitiflora by Targeting CDK8 in Triple-Negative Breast Cancer Cells. Journal of Natural Products. 82(11). 3140–3149. 27 indexed citations
6.
Bach, Duc‐Hiep, Thi-Thu-Trang Luu, Donghwa Kim, et al.. (2018). BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells. Molecular Therapy — Nucleic Acids. 12. 817–828. 44 indexed citations
7.
Bach, Duc‐Hiep, Donghwa Kim, Song Yi Bae, et al.. (2018). Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells. Molecular Therapy — Nucleic Acids. 11. 455–467. 59 indexed citations
8.
Bach, Duc‐Hiep, Nguyen Phuoc Long, Thi-Thu-Trang Luu, et al.. (2018). The Dominant Role of Forkhead Box Proteins in Cancer. International Journal of Molecular Sciences. 19(10). 3279–3279. 75 indexed citations
9.
Bach, Duc‐Hiep, Jianyu Liu, Won Kyung Kim, et al.. (2017). Synthesis and biological activity of new phthalimides as potential anti-inflammatory agents. Bioorganic & Medicinal Chemistry. 25(13). 3396–3405. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026